This inventor holds 17 USPTO granted patents and 2 published patent applications and 8 EPO patents, primarily in Cancer Therapeutics. Top assignees: Genentech, Inc., Plexxikon Inc.. Active years: 2007-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- South San Francisco, CA (US) (2015 - 2017)
- Lafayette, CA (US) (2007 - 2023)
- Orinda, CA (US) (2023)
Company Filing History:
Years Active: 2007-2026
Areas of Expertise:
Title: Exploring the Innovative World of Weiru Wang: A Pioneer in Inhibitors of HPK1
Introduction:
Weiru Wang, a talented inventor hailing from Lafayette, CA (US), has made significant contributions to the field of biomedical research with his groundbreaking patents and inventions. With a remarkable track record of 15 patents to his name, Weiru Wang has consistently demonstrated his expertise and prowess in innovation.
Latest Patents:
Weiru Wang's latest patents revolve around the development of revolutionary compounds for inhibiting HPK1 (hematopoietic kinase 1) – a key target in the treatment of HPK1-dependent disorders and in enhancing immune responses. His patents on 8-aminoisoquinoline compounds and isoquinolines as inhibitors of HPK1 showcase his commitment to advancing the field of biomedicine through novel therapeutic solutions.
Career Highlights:
Having worked with prestigious companies such as Genentech, Inc. and Plexxikon Inc., Weiru Wang has honed his skills and expertise in the pharmaceutical industry. His innovative mindset and dedication to scientific research have paved the way for numerous breakthroughs in the development of cutting-edge pharmaceutical compounds.
Collaborations:
Weiru Wang's collaborations with esteemed colleagues like Dean R Artis and Prabha N Ibrahim have been instrumental in shaping his inventive journey. Together, they have synergized their talents and knowledge to foster a culture of innovation and excellence in the field of biomedical research.
Conclusion:
In conclusion, Weiru Wang stands as a beacon of innovation in the realm of biomedical research, with his groundbreaking inventions and patents serving as a testament to his unwavering commitment to advancing medical science. His contributions to the development of inhibitors of HPK1 have not only pushed the boundaries of scientific knowledge but have also opened up new possibilities for the treatment of HPK1-dependent disorders. Weiru Wang's legacy as a pioneering inventor is sure to inspire future generations of innovators to push the boundaries of what is possible in the world of biomedicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile